Southeast Asset Advisors’s Novartis NVS Stock Holding History

Southeast Asset Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Hold	6,716	–	–	0.11%	108
2026 Q1	$1.03M	Buy	6,716 +225	+3%	+$34.5K	0.11%	101
2025 Q4	$895K	Hold	6,491	–	–	0.09%	111
2025 Q3	$832K	Buy	6,491 +771	+13%	+$94.1K	0.09%	110
2025 Q2	$692K	Buy	5,720 +3,100	+118%	+$349K	0.08%	110
2025 Q1	$292K	Hold	2,620	–	–	0.04%	156
2024 Q4	$255K	Hold	2,620	–	–	0.03%	148
2024 Q3	$301K	Hold	2,620	–	–	0.03%	139
2024 Q2	$279K	Sell	2,620 -64	-2%	-$6.42K	0.03%	144
2024 Q1	$260K	Hold	2,684	–	–	0.03%	148
2023 Q4	$271K	Hold	2,684	–	–	0.04%	143
2023 Q3	$273K	Buy	+2,684	New	+$272K	0.04%	136

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Southeast Asset Advisors's NVS Position: Q2 2026 in Review

Southeast Asset Advisors held its Novartis (NVS) position steady in Q2 2026 at 6,716 shares worth $1.05M. The position accounts for 0.11% of the portfolio, ranked #108.

Southeast Asset Advisors first reported a position in NVS in Q3 2023 and has held it in 12 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Southeast Asset Advisors held 6,716 shares of Novartis worth $1.05M as of Q2 2026.
Southeast Asset Advisors left its Novartis share count unchanged in Q2 2026.
Novartis made up 0.11% of Southeast Asset Advisors's portfolio in Q2 2026, its #108 holding.
Southeast Asset Advisors first reported a position in Novartis in Q3 2023 and has held it in 12 quarters since.
1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Southeast Asset Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.